ClaimsPeople

Ray Kurzweil

Ray Kurzweil is an author of books on artificial intelligence and the technological singularity, including The Singularity Is Near, The Singularity Is Nearer, The Age of Spiritual Machines and How to Create a Mind; he received the 1999 National Medal of Technology and Innovation, became Director of Engineering at Google and co-founded Singularity University.

894 claims collected, 397 researched, 78 resolved. Report of 5 November 2026, method 0.1.0+28da144b.

Scores by kind of claim

Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.

  • Factual claims

    Statements about the present or the past, checked against the record: did they hold up?

    68 61 75

    High confidence, 69 factual claims resolved. From 13 documents, 2000 to 2026; 15 documents sampled from 30 candidates found.

    Not scored: 61 unresolvable, 14 checkable only against their own records.

    See the factual claims

  • Predictions

    Statements about events outside the person's control, checked once they fell due: did they come true?

    42 25 60

    Low confidence, 9 predictions resolved. From 4 documents, 2001 to 2020; 15 documents sampled from 30 candidates found.

    Not scored: 140 unresolvable, 2 checkable only against their own records. 98 more fall due later.

    Does not yet allow for how likely each prediction was when made.

    See the predictions

  • Promises

    Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?

    Insufficient record: 0 promises resolved, 5 needed for a score.

    Not scored: 1 not yet due.

    See the promises

All types combined: 65 (likely 58 to 71, high confidence), from 78 claims: 69 factual claims, 9 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.

Ray Kurzweil's claims

9 claims

9 claims, sorted by newest said. Choose a claim to read it in full.
VerdictKindSaidClaimTopic
Mostly false Prediction May 2020 Within several years all vaccine and medication development could be done by combining AI with biotechnology. Prediction · May 2020 Science and research methods
Mostly false Prediction 3 Jun 2015 Kurzweil predicted that humans will gradually merge with technology and enhance themselves. Prediction · 3 Jun 2015 AI timelines and forecasting
Resolved true Prediction 12 Dec 2002 Ten or 15 years after 2002, computing will move to three-dimensional circuits as integrated circuits run out of steam. Prediction · 12 Dec 2002 AI compute, hardware and data
Mostly false Prediction Jan 2001 Computers will be able to read on their own, understanding and modeling what they read, by the second decade of the 21st century. Prediction · Jan 2001 AI capabilities
Mostly false Prediction Jan 2001 Supercomputers will achieve one human brain's capacity by 2010, and personal computers by around 2020. Prediction · Jan 2001 AI timelines and forecasting
Mostly false Prediction Jan 2001 Exponential-outlook views of the economy will prevail gradually over the next several years, producing a strong continuing updraft for the stock market. Prediction · Jan 2001 Economics and markets
Resolved true Prediction Jan 2001 Within a couple of decades of 2001, the computational power to emulate the human brain will be available. Prediction · Jan 2001 AI timelines and forecasting
Mostly false Prediction 2001 By the end of the decade (the 2000s), full immersion visual-auditory environments will be available, with images written onto the retinas by eyeglasses and contact lenses. Prediction · 2001 Technology
Resolved false Prediction 2001 Within ten years of 2001, biotechnology advances will add more than a year of life expectancy every year. Prediction · 2001 Science and research methods
Back to the list

Ray Kurzweil

Open its page

Prediction Science and research methods

“This is where combining AI with biotechnology is headed, and within several years all vaccine and medication development could be done this way.”

Ray Kurzweil, columnist May 2020 AI-powered bio-tech can help deploy a vaccine in record time (Kurzweil Library / Wired)

Within several years all vaccine and medication development could be done by combining AI with biotechnology.

Mostly false False in substance, right in a detail.

Said for an organisation they lead or work for; it counts on both records.

What would count as true or false

Strongly hedged prediction ('could'); judge at a horizon of several years (about 2025). True: by about 2025, essentially all vaccine and medication development uses AI combined with biotechnology (computational simulation and AI-driven discovery) as standard. Mostly true: AI-plus-biotech methods are used in the large majority of development programs industry-wide. Mixed: AI is widely adopted, but in roughly half of development or only at some stages. Mostly false: AI is used in a notable minority of programs or only in early discovery, with most development still done by conventional methods. False: AI plays a marginal role in vaccine and drug development by the horizon. Because of the hedging, the claim is judged on whether the trajectory reached 'all' development being done this way, not on mere possibility.

Evidence

  1. New Insights On the Impact of AI-Enabled Solutions | Applied Clinical Trials Online Applied Clinical Trials Online (Tufts Center for the Study of Drug Development analysis by Ken Getz) · 11 June 2025
    “As of late 2024, only 11% of the nearly 80 companies responding reported fully implementing AI/ML to enable and support clinical trial activities. An additional 22% reported partially implementing AI/ML solutions.”
  2. Pharma's AI Is Paying Off in the Factory, Not the Clinic. Only 17% Have Full Governance. Deployed (AI Media House) · 3 November 2026
    “The share reporting measurable AI outcomes in supply chain and manufacturing rose from 29% to 53%, the largest jump of any function. In drug discovery, it rose from 17% to 35%.”
  3. 2025 AI Observatory report European Medicines Agency · 12 May 2026
    “Multiple AI applications were discussed with applicants, including industry, in 2025. Most applications of AI relate to data handling and analysis, across several domains of the medicines development lifecycle, highlighting the growing potential of AI in medicines development.”

Reasoning

E1 reports that as of late 2024 only 11% of nearly 80 surveyed companies had fully implemented AI/ML for clinical trial activities, with another 22% partially implementing it. E2 reports that measurable AI outcomes in drug discovery rose from 17% to 35%, a notable minority. E3 says AI applications discussed with the EMA in 2025 mostly concerned data handling and analysis and frames this as growing potential, not standard practice. The evidence shows AI used in a notable minority of programs, not essentially all development, which fits the 'mostly false' tier.

Cite this claim

Ray Kurzweil, “Within several years all vaccine and medication development could be done by combining AI with biotechnology.” (said May 2020). Verdict: mostly false. Reliability API, claim c_9e84b840a18f, method 0.1.0+28da144b. https://epistacklabs.com/claims/c_9e84b840a18f

Claims without a verdict

Is a verdict here wrong, or do you speak for Ray Kurzweil? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.